$2.76-8.51 (-75.51%)
News25/Ratings0
Latest news
25 items- PROSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AGBELLEVUE, Wash. and ZUG, Switzerland, July 8, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced the official roadmap for a targeted $50 million security token offering (STO) planned for launch in the second half of 2025 under Regulation D of the U.S. Securities Act. The token, with the working title OSRT, will be a securitized digital asset representing OSR Holdings' equity exposure and is designed to align with the company's blockchain-based capital strategy. As part of this roadmap
- PROSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH TokenSEOUL, South Korea and ZUG, Switzerland, May 22, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ:OSRH), a public company dedicated to advancing innovation in healthcare and wellness, announced today that it has entered into a Memorandum of Understanding (MOU) with BCM Europe AG, its major shareholder, and Taekwondo Cooperative (TKD Coop), a global Taekwondo community organization, to explore the joint development of a security token, provisionally named the "OSRH Token". The initiative aims to enhance access to crypto-based liquidity and provide a basis for OSRH to launch crypto treasury strategies.
- INSIDERSEC Form 3 filed by new insider Kim Sang Harry3 - OSR Holdings, Inc. (0001840425) (Issuer)
- INSIDERSEC Form 3 filed by new insider Cho Joong Myung3 - OSR Holdings, Inc. (0001840425) (Issuer)
- INSIDERSEC Form 3 filed by new insider Barberis Alcide3 - OSR Holdings, Inc. (0001840425) (Issuer)
- SECBellevue Life Sciences Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Leadership Update, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Financial Statements and Exhibits8-K - OSR Holdings, Inc. (0001840425) (Filer)
- INSIDERSEC Form 3 filed by new insider Bang Gihyoun3 - OSR Holdings, Inc. (0001840425) (Issuer)
- INSIDERSEC Form 3 filed by new insider Jee Hyuk Joo3 - OSR Holdings, Inc. (0001840425) (Issuer)
- INSIDERLarge owner Bellevue Global Life Science Investors Llc acquired 43,000 shares, increasing direct ownership by 2% to 2,043,500 units (SEC Form 4)4 - OSR Holdings, Inc. (0001840425) (Issuer)
- INSIDERPresident and CEO Hwang Kuk Hyoun acquired 10,698,604 shares (SEC Form 4)4 - OSR Holdings, Inc. (0001840425) (Issuer)
- INSIDERNew insider Bellevue Capital Management Llc claimed ownership of 3,123,970 shares (SEC Form 3)3 - OSR Holdings, Inc. (0001840425) (Issuer)
- INSIDERNew insider Bcm Europe Ag claimed ownership of 7,531,634 shares (SEC Form 3)3 - OSR Holdings, Inc. (0001840425) (Issuer)
- SECSEC Form 25-NSE filed by Bellevue Life Sciences Acquisition Corp.25-NSE - OSR Holdings, Inc. (0001840425) (Subject)
- PROSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business CombinationOSR Holdings, Inc. to Begin Trading on the Nasdaq Stock Market LLC on Tuesday, February 18, 2025Under the symbol "OSRH" SEOUL, South Korea, Feb. 14, 2025 /PRNewswire/ -- OSR Holdings, Inc. (formerly Bellevue Life Sciences Acquisition Corp. (the "Company")) and OSR Holdings Co., Ltd. ("OSR") announced today the completion of their business combination (the "Business Combination"). The Company now operates as "OSR Holdings, Inc." following the successful completion of the Business Combination. Beginning on Tuesday, February 18, 2025, the common stock and warrants of the Company
- SECSEC Form 425 filed by Bellevue Life Sciences Acquisition Corp.425 - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
- SECBellevue Life Sciences Acquisition Corp. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits8-K - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)
- PRBellevue Life Sciences Acquisition Corp. Announces Approval of Business Combination Proposal And Name Change to OSR Holdings, Inc.SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ -- Bellevue Life Sciences Acquisition Corp. ("BLAC") announced today the approval of each of the proposals presented at the special meeting of its stockholders (the "Special Meeting") held today, including the proposal for the business combination with OSR Holdings Co., Ltd. (the "Transaction"). BLAC expects the Transaction to close following receipt of foreign investment approval from the Industrial Bank of Korea, which is expected on February 14, 2025. Following the Special Meeting, BLAC filed its Amended and Restated Certific
- SECSEC Form EFFECT filed by Bellevue Life Sciences Acquisition Corp.EFFECT - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)
- SECSEC Form 424B3 filed by Bellevue Life Sciences Acquisition Corp.424B3 - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)
- SECAmendment: SEC Form S-4/A filed by Bellevue Life Sciences Acquisition Corp.S-4/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)
- SECAmendment: SEC Form S-4/A filed by Bellevue Life Sciences Acquisition Corp.S-4/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)
- SECBellevue Life Sciences Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)
- SECBellevue Life Sciences Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement8-K - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Bellevue Life Sciences Acquisition Corp.SCHEDULE 13G/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Subject)
- SECAmendment: SEC Form S-4/A filed by Bellevue Life Sciences Acquisition Corp.S-4/A - Bellevue Life Sciences Acquisition Corp. (0001840425) (Filer)